OP01: In-depth characterization of host-genetics and gut microbiome unravels novel host-microbiome interactions in Inflammatory Bowel DiseaseECCO'19 Copenhagen 2019
1
OP02: The role of PTPN2 SNP in the pathogenesis of fibrosis in Crohn’s DiseaseECCO'19 Copenhagen 2019
1
OP07: Analysing intestinal organoids in a multi-omics, systems biology framework to investigate functional processes affected in Crohn’s disease due to autophagy impairmentECCO'19 Copenhagen 2019
1
OP10: Systems genomics of ulcerative colitis: combining GWAS and signalling networks for patient stratification and individualised drug targeting in ulcerative colitisECCO'19 Copenhagen 2019
1
OP11: Organoids derived from inflamed intestinal biopsies of patients with ulcerative colitis lose their inflammatory phenotype during ex vivo cultureECCO'19 Copenhagen 2019
1
OP12: Targeting inflammation in ulcerative colitis by inhibiting glucose uptakeECCO'19 Copenhagen 2019
1
OP13: Molecular response to ustekinumab in moderate-to-severe ulcerative colitis by serum protein and biopsy gene expression analysis: Results from the UNIFI phase 3 induction studyECCO'19 Copenhagen 2019
1
OP14: Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately-to-severely active ulcerative colitis: data from the U-ACHIEVE studyECCO'19 Copenhagen 2019
1
OP16: A randomised, multicentre, double-blind, placebo-controlled study of a targeted release oral cyclosporine formulation in the treatment of mild to moderate ulcerative colitis: efficacy resultsECCO'19 Copenhagen 2019
1